GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IRLAB Therapeutics AB (OSTO:IRLAB A) » Definitions » E10

IRLAB Therapeutics AB (OSTO:IRLAB A) E10 : kr-2.02 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is IRLAB Therapeutics AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

IRLAB Therapeutics AB's adjusted earnings per share data for the three months ended in Mar. 2025 was kr-0.650. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-2.02 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-06-26), IRLAB Therapeutics AB's current stock price is kr3.85. IRLAB Therapeutics AB's E10 for the quarter that ended in Mar. 2025 was kr-2.02. IRLAB Therapeutics AB's Shiller PE Ratio of today is .


IRLAB Therapeutics AB E10 Historical Data

The historical data trend for IRLAB Therapeutics AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IRLAB Therapeutics AB E10 Chart

IRLAB Therapeutics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

IRLAB Therapeutics AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -2.02

Competitive Comparison of IRLAB Therapeutics AB's E10

For the Biotechnology subindustry, IRLAB Therapeutics AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IRLAB Therapeutics AB's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IRLAB Therapeutics AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where IRLAB Therapeutics AB's Shiller PE Ratio falls into.


;
;

IRLAB Therapeutics AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IRLAB Therapeutics AB's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.65/132.8245*132.8245
=-0.650

Current CPI (Mar. 2025) = 132.8245.

IRLAB Therapeutics AB Quarterly Data

per share eps CPI Adj_EPS
201312 0.000 100.541 0.000
201412 0.000 100.225 0.000
201512 0.000 100.276 0.000
201603 -0.497 100.751 -0.655
201606 -0.253 101.019 -0.333
201609 -0.413 101.138 -0.542
201612 -0.566 102.022 -0.737
201703 -0.389 102.022 -0.506
201706 -0.299 102.752 -0.387
201709 -0.582 103.279 -0.748
201712 -0.364 103.793 -0.466
201803 -0.444 103.962 -0.567
201806 -0.639 104.875 -0.809
201809 -0.075 105.679 -0.094
201812 -0.452 105.912 -0.567
201903 -0.448 105.886 -0.562
201906 -0.737 106.742 -0.917
201909 -0.521 107.214 -0.645
201912 -0.680 107.766 -0.838
202003 -0.420 106.563 -0.524
202006 -0.540 107.498 -0.667
202009 -0.550 107.635 -0.679
202012 -0.400 108.296 -0.491
202103 -0.390 108.360 -0.478
202106 -0.510 108.928 -0.622
202109 2.350 110.338 2.829
202112 -0.450 112.486 -0.531
202203 -0.560 114.825 -0.648
202206 -0.520 118.384 -0.583
202209 -0.460 122.296 -0.500
202212 -0.640 126.365 -0.673
202303 -1.150 127.042 -1.202
202306 -0.870 129.407 -0.893
202309 -0.740 130.224 -0.755
202312 -0.670 131.912 -0.675
202403 -0.750 132.205 -0.754
202406 -0.140 132.716 -0.140
202409 -0.610 132.304 -0.612
202412 -0.100 132.987 -0.100
202503 -0.650 132.825 -0.650

Add all the adjusted EPS together and divide 10 will get our e10.


IRLAB Therapeutics AB  (OSTO:IRLAB A) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


IRLAB Therapeutics AB E10 Related Terms

Thank you for viewing the detailed overview of IRLAB Therapeutics AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


IRLAB Therapeutics AB Business Description

Traded in Other Exchanges
N/A
Address
Arvid Wallgren Backe 20, Goteborg, SWE, 413 46
IRLAB Therapeutics AB is a drug discovery and development company providing novel treatments for disorders of the brain. The company focuses on innovative treatments and quality of life for patients with neurological and psychiatric illnesses. It is engaged in programs targeting core dysfunctions in Parkinson's disease and dementias. In addition, it is also involved in the clinical development of novel compounds which aims at offering improved clinical benefit for patients with Parkinson's disease. The company's current clinical candidates, mesdopetam (IRL790) and pirepemat (IRL752), both of which have successfully gone through Phase I safety and Phase IIa efficacy proof-of-concept studies, are now in Phase IIb trials.

IRLAB Therapeutics AB Headlines

No Headlines